ods (Ն 5 days) causes reduced graft volumes 12 and decreased TH-positive cell populations. 39, 43 To increase survival of TH-positive dopaminergic neurons in cool storage, we have supplemented our hibernation medium with GDNF. 1, 30, 32, 33 Both GDNF and a number of related factors are a newly characterized group of trophic factors related to the transforming growth factor-␤ superfamily that signal through a RET receptor tyrosine kinase. 6, 16, [54] [55] [56] Glial cell line-derived neurotrophic factor was initially isolated as a trophic factor for midbrain dopaminergic neurons. 27 It has been shown to increase TH-positive cell survival and fiber outgrowth when infused directly at the graft site; additionally it protects dopaminergic cells from neurotoxins such as 6-hydroxydopamine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, and 1-methyl-4-phenylpyridine. 7, 14, 19, 24, 45, 47, 48, 52, 53, 59, 60 Furthermore, GDNF has been implicated in the natural development of the nigrostriatal pathway, 25, 51 and it promotes expression of the typical midbrain dopaminergic neuron morphology in mesencephalon-derived progenitor cells. 40 In our studies of GDNF, we found that cool storage in GDNF-supplemented hibernation medium improves cell survival, fiber outgrowth, and promotes faster recovery in the rat model of PD. We have also shown that GDNF supplementation of hibernation medium protects human fetal dopaminergic neurons in cool storage, and we have applied this strategy to storage of VM tissue for 6 days prior to transplantation in patients with PD.
32,33
The objective of the present study was to investigate the efficacy of cool storage of fetal VM tissue in GDNF-supplemented hibernation medium beyond 6 days without decreased dopaminergic cell viability.
MATERIALS AND METHODS

Tissue Collection and Hibernation
Ventral mesencephalons were dissected in 27 Day 14 rat fetuses. Three of these 27 VMs were placed in culture immediately as fresh controls. The remaining 24 samples were sectioned sagittally along their midlines to form 48 equal pieces of hemimesencephalons. Half of these were placed in 6-, 9-, 12-, and 15-day hibernation groups that re1ceived GDNF-supplemented hibernation medium, and the other half were placed in 6-, 9-, 12-, and 15-day hibernation groups that received hibernation medium alone. Hibernation consisted of cool storage for 6, 9, 12, or 15 days at 4°C in 500 L of a low-sodium, phosphate-buffered, calcium-free storage medium. 1, 18, 30 For GDNF-supplemented hibernation, recombinant human GDNF (1 g/ml; Prepro Tech Inc., Rocky Hill, NJ) was added to the hibernation medium on the 1st day of hibernation.
Cell Culture
Ventral mesencephalon tissue was incubated in 0.1% trypsin in 0.05% DNase/DMEM for 20 minutes at 37°C and then washed in 0.05% DNase/DMEM to stop trypsin activity (trypsin, DNase, and DMEM; Sigma, Chicago, IL). The tissue was mechanically dissociated by trituration using successively smaller sterilized micropipette tips until a "chunky" cell suspension was achieved. The cell suspension was centrifuged at 300 G for 5 minutes by using a small bench-top centrifuge, and the cell pellet was subsequently resuspended in culture medium. Cell count and viability was determined using the trypan blue exclusion test. Cell suspensions were plated onto a polyϪ L-lysine-coated substrate (10 g/ml; Sigma) at 200,000 cells/cm 2 in serum-free media consisting of DMEM/F12 (Sigma) 3:1, B27 (Gibco, Burlington, ON, Canada) 1:50 penicillin 100 U/ml, and streptomycin 100 g/ml. All cultures were maintained at 37°C in a humidified incubator with a 5% CO 2 atmosphere for 48 hours.
Tyrosine Hydroxylase Immunohistochemistry and Cell Counts
Immunohistochemistry for TH was conducted on 4% paraformaldehyde fixed slides. Briefly, cell cultures were quenched in 3% H 2 O 2 /10% MeOH for 10 minutes, followed by blocking for 1 hour with normal swine serum in 0.3% Triton-X100. Cell cultures were incubated in primary antibody, rabbit anti-TH (1:750; Pel Freeze, Rogers, AK), overnight at room temperature. They were then incubated in swine anti-rabbit secondary antibody and avidin-biotin complex (Vector Dimension, Burlington, ON, Canada) for 1 hour each. Finally, the cultures were placed in diaminobenzidine/H 2 O 2 for 5 to 10 minutes.
Cell counting was performed on cells stained for TH immunoreactivity. Cell counts were made using an eyepiece grid (0.25 ϫ 0.25 mm divided into a 10 ϫ 10 grid), counting TH-positive cells and cresyl violet-stained non-TH-positive cells within a fixed area. Sample areas were chosen using a randomized number generator that generated (x and y) coordinates within the total culture area. All data were statistically analyzed using two-way analysis of variance and two-sample t-tests.
RESULTS
All groups yielded healthy-appearing cultures when examined under phase-contrast microscopy during the 48-hour culture period (Fig. 1) . The percentage of TH-positive cells was increased in the GDNF-supplemented group for all hibernation periods compared with the groups stored in hibernation medium alone; however, this percentage was only statistically significantly higher in the 6-and 9-day groups (Fig. 2) . This increase in percentage of TH immunoreactivity was also significantly higher than fresh (immediately cultured) controls. The percentage of TH-positive cells declined after 9 days in hibernation, becoming significantly less than that observed fresh control values in the 15-day hibernation group.
DISCUSSION
It is estimated that only 1 to 20% of grafted dopaminergic cells survive neural transplantation. Consequently, a large amount of cells-derived from multiple donor fetuses-is required for a transplant to produce meaningful functional outcomes. 22, 28, 58 Because of the difficulties surrounding the acquisition of fetal donors and the limited supply of donors of the correct gestational age, tissue storage is desirable to allow collection over several days. Furthermore, complete microbiological screening for infectious diseases in fetal tissues is more easily accom-plished when storage times are extended. Tissue storage methods such as freeze storage and cool storage for greater than 3 days, however, result in decreased graft volumes and decreased functional recovery in animal studies 4,11,43,44 and clinical trials. 41, 50 This is thought to be due to increased cell fragility and susceptibility to oxidative stress.
4,39
Fortunately, there is evidence that TH-positive cell survival may be augmented by the addition of neuroprotectant factors to the hibernation medium. 1, 15, 30, 38 GrasbonFrodl, et al., 15 have demonstrated increased hibernated rat TH-positive cell survival and functional recovery in the rat model of PD by adding a lazaroid to the hibernation medium. Furthermore, our group has previously demonstrated that addition of the trophic factor GDNF to the hibernation medium as well as to the cell suspension prior to transplantation increases the absolute number of surviving TH cells per graft, compared with using tissue untreated with GDNF or tissue treated with GDNF only at the cell suspension stage. 1 We subsequently demonstrated that adding GDNF to the hibernation medium resulted in increased fiber density in the zone surrounding the graft, as well as increased functional recovery as measured by the adjusting step test in the rat model of PD. 30 We have also observed that human VM tissue stored for 6 days in non-GDNF-supplemented hibernation medium undergoes a 31% decline in TH-positive cell populations compared with fresh controls and tissue hibernated with GDNF. 32 In the present study, we examined GDNF-supplemented hibernation for extended time periods of 6 to 15 days. The GDNF-supplemented hibernation promotes a significant increase of the percentage of TH immunoreactivity cells when tissue is stored up to 9 days at 4°C (p Ͻ 0.02) compared with both fresh control (immediately cultured) and non-GDNF-supplemented hibernation groups. This increase is not observed at 12 and 15 days (p Ͼ 0.05). Our results suggest that storing fetal tissue in hibernation media for up to 9 days is beneficial, when supplemented with GDNF. This observation has important practical implications for neural transplantation because hibernation with GDNF will enhance the percentage of dopaminergic cells and allow the pooling of fetal tissue over several days, enabling a sufficient quantity of VM cells to be collected to produce meaningful functional outcomes in transplanted patients undergoing transplantation.
Although the precise molecular mechanism(s) underlying the "dopaminotrophic" effect of GDNF remains unclear, one suggested mechanism is the suppression of caspase activity. 46 Caspases are mediators of neuronal apoptosis, 17 and reactive oxidative stress has been demonstrated to cause apoptosis via caspase activation. 57 Hibernation of tissue may lead to the buildup of intracellular free radicals due to ischemia, and reactive oxidative metabolites may be released from lysis of cells.
5,15 Thus GDNF may prevent oxidative stress-induced apoptosis by preventing caspase activation.
It is likely that the antiapoptotic effect of GDNF involves protein synthesis via induction of nuclear transcription. Sawada and colleagues 46 have reported that simultaneous administration of GDNF with apoptosisinducing neurotoxins to midbrain neurons fails to rescue the neurons from the action of the toxins. 46 This observation is in line with data obtained by our group showing that GDNF-supplemented hibernation of VM tissue prior to transplantation led to significantly increased fiber outgrowth and percentage of TH-positive cells per graft, compared with transplants of fresh VM tissue grafted with (but not stored in) GDNF. These data would appear to suggest that the antiapoptotic actions of GDNF require the de novo synthesis of proteins. posed that there exists a population of TH-positive cells destined to die within the first 24 hours in hibernation or after grafting. Preincubation with GDNF in the cell hibernation medium may rescue this particular cell population from early cell death.
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CONCLUSIONS
Glial cell line-derived neurotrophic factor has been shown to enhance VM grafts and increase cell survival in the rat model of PD, as well as prevent the decline in human fetal VM TH-positive cell survival that is typically seen beyond 3 days in cool storage. In the present study we found that exposing rat VMs to GDNF during tissue hibernation increases the percentage of TH-immunoreactive cell populations for up to 9 days following extraction from fetuses, compared with fresh (immediately cultured) control. This finding bears clinical importance because the technique of GDNF-supplemented hibernation of fetal VM cells will enable longer storage periods of graft material, a critical practical issue in neural transplantation for PD. 
